Cargando...
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer
BACKGROUND: Two first-line (1L) bevacizumab trials showed the prognostic value of primary tumour location in metastatic colorectal cancer (mCRC). In this retrospective subgroup analysis, further analysis of the predictive effect of bevacizumab is presented. METHODS: Patients with sidedness informati...
Gardado en:
| Publicado en: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group UK
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6288128/ https://ncbi.nlm.nih.gov/pubmed/30487637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0304-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|